Lachiewicz, A. M., Shah, M., Der, T., Cyr, D., Al-Khalidi, H. R., Lindsell, C., … Bozzette, S. A. (2024). Resource Use in the Randomized Master Protocol for Immune Modulators for Treating COVID-19 (ACTIV-1 IM) (Accepted). CHEST Critical Care, 2(4), 100095–100095. https://doi.org/10.1016/j.chstcc.2024.100095

Lachiewicz, Anne M., Miloni Shah, Tatyana Der, Derek Cyr, Hussein R. Al-Khalidi, Christopher Lindsell, Vivek Iyer, et al. “Resource Use in the Randomized Master Protocol for Immune Modulators for Treating COVID-19 (ACTIV-1 IM) (Accepted).” CHEST Critical Care 2, no. 4 (December 2024): 100095–100095. https://doi.org/10.1016/j.chstcc.2024.100095.

Lachiewicz AM, Shah M, Der T, Cyr D, Al-Khalidi HR, Lindsell C, et al. Resource Use in the Randomized Master Protocol for Immune Modulators for Treating COVID-19 (ACTIV-1 IM) (Accepted). CHEST Critical Care. 2024 Dec;2(4):100095–100095.

Lachiewicz, Anne M., et al. “Resource Use in the Randomized Master Protocol for Immune Modulators for Treating COVID-19 (ACTIV-1 IM) (Accepted).” CHEST Critical Care, vol. 2, no. 4, Elsevier BV, Dec. 2024, pp. 100095–100095. Crossref, doi:10.1016/j.chstcc.2024.100095.

Lachiewicz AM, Shah M, Der T, Cyr D, Al-Khalidi HR, Lindsell C, Iyer V, Khan A, Panettieri R, Rauseo AM, Maillo M, Schmid A, Jagpal S, Powderly WG, Bozzette SA. Resource Use in the Randomized Master Protocol for Immune Modulators for Treating COVID-19 (ACTIV-1 IM) (Accepted). CHEST Critical Care. Elsevier BV; 2024 Dec;2(4):100095–100095.